US-approved vaccines effective against B1617 variant of Covid-19: US health official

WHO classified the B1617 SARS-CoV-2 variant, and confirmed that the variant was first detected in India

Comments

Popular posts from this blog

Infosys lays off hundreds after failing internal assessments in Mysuru

Congress groomed me not to sit at home: Shivakumar

Greater Bengaluru Committee proposes seven municipal corporations